RA is opening my eyes to the complex world of high level, biological medicines. According to one source, the global market for TNF inhibitors (e.g. Enbrel, Humira, etc.) was $13.5 billion in 2008. Understandably, it takes years of research, clinical trials, and approval processes in multiple countries before a new medication hits the market. And recouping those costs is important since the pharmaceutical companies have so much invested. But these dollar amounts amaze me when I consider the exorbitant retail price (about $1,800 a month) and the fact that the FDA gives a 14 year lock on biologicals before making it generic (7 years for other drugs).
- FreefallDecember 11, 2013 - 11:46 am
- Sky HighDecember 6, 2013 - 4:58 pm
- My Decision To Not Use Medicines Right Now Is All About Personal ResponsibilityNovember 6, 2013 - 11:13 am
- Rock BottomOctober 29, 2013 - 12:04 pm
- How I Keep On Moving While Living With Rheumatoid ArthritisOctober 17, 2013 - 10:23 am